Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
The role of various segments (gag or v-abl) of the Abelson murine leukemia virus (A-MuLV) genome in both lymphoid cell and fibroblast transformation was examined by deletion of areas from cloned, plasmid DNA representations of the genome. The deleted plasmids were tested by transfection into fibroblasts and by infection of bone marrow cells using virus stocks derived from the fibroblast transfectants. Deletion of gag coding sequence from the A-MuLV protein did not affect fibroblast transforming activity but abolished lymphoid transforming activity. The gag- A-MuLV genomes were very unstable in transformed fibroblasts leading to large secondary deletions in v-abl sequences. The gag- A-MuLV proteins also had lower autophosphorylation than their gag+ counterparts although cells transformed by gag- virus had a normal elevation of protein-linked phosphotyrosine. Systematic deletion of v-abl sequences showed that only 45,000 to the 130,000 molecular weight of v-abl sequence in the A-MuLV protein is needed for fibroblast transformation and, at most, slightly more is needed for lymphoid cell transformation.
D000011:Abelson murine leukemia virus / Q000235:genetics*; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002472:Cell Transformation, Viral; D005347:Fibroblasts / Q000166:cytology; D009052:Leukemia Virus, Murine / Q000235:genetics*; D008214:Lymphocytes / Q000166:cytology; D051379:Mice; D008970:Molecular Weight; D010455:Peptides / Q000235:genetics*; D019000:Phosphotyrosine; D015291:Transforming Growth Factors; D014443:Tyrosine / Q000031:analogs & derivatives / Q000032:analysis
D010455:Peptides; D019000:Phosphotyrosine; D014443:Tyrosine; D015291:Transforming Growth Factors